Results 1 to 10 of about 66,109 (299)
An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study
Frontiers in Pharmacology, 2020 AimPolypharmacy is becoming a global health problem. The aims of this study were to evaluate the temporal trends in the prevalence of polypharmacy in Sweden and to explore polypharmacy disparities by age, gender, education, and immigration status ...
Jan Sundquist +2 more
exaly +3 more sources
Frontiers in Pharmacology, 2022 Background: Polypharmacy has become a global health problem and is associated with adverse health outcomes in the elderly. This study evaluated the prevalence of polypharmacy and hyper-polypharmacy in elderly patients in South Korea during 2010–2019 ...
Dong-Sook Kim, Kim Dong-Sook
exaly +3 more sources
An overview of prevalence, determinants and health outcomes of polypharmacy
Therapeutic Advances in Drug Safety, 2020 A high rate of polypharmacy is, in part, a consequence of the increasing proportion of multimorbidity in the ageing population worldwide. Our understanding of the potential harm of taking multiple medications in an older, multi-morbid population, who are
Mina Khezrian +2 more
exaly +2 more sources
The evolution of polypharmacy: appropriate and problematic polypharmacy, choosing the right strategy and tactics [PDF]
Медицинский совет, 2021 The evolution of polypharmacy, which for many years consisted of quantifying concurrently prescribed drugs, has led to an qualitative description: “appropriate polypharmacy”, which may be beneficial for some patients, and “problematic polypharmacy ...
M. V. Leonova
doaj +3 more sources
Polypharmacy in people with dementia: a nationwide Danish study [PDF]
Alzheimer’s Research & TherapyBackground Polypharmacy, particularly central nervous system (CNS)-active polypharmacy, is widespread in individuals with dementia and may accelerate cognitive decline and increase hospitalization and mortality risks. Identifying the extent and trends of
Nelsan Pourhadi +5 more
doaj +2 more sources
Prevalence and factors associated with polypharmacy: a systematic review and Meta-analysis
BMC Geriatrics, 2022 Introduction Polypharmacy is commonly associated with adverse health outcomes. There are currently no meta-analyses of the prevalence of polypharmacy or factors associated with polypharmacy.
Mahin Delara +7 more
doaj +1 more source
Polypharmacy trajectories among older women with and without dementia: A longitudinal cohort study
Exploratory Research in Clinical and Social Pharmacy, 2021 Background: Although multiple medications are often utilized to achieve optimal treatment outcomes, polypharmacy (use of five or more medications) among older population is associated with several detrimental effects.
Kailash Thapaliya +2 more
doaj +1 more source
Therapeutic Advances in Psychopharmacology, 2021 Aims: This cross-sectional pharmacoepidemiologic study examined the prevalence of polypharmacy and psychotropic polypharmacy among inpatients in a tertiary psychiatric hospital in Belgium.
Jeroen Govaerts +8 more
doaj +1 more source
Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016.
PLoS ONE, 2021 Background/objectivesWith an aging population suffering from increased prevalence of chronic conditions in the United States (U.S.), a large portion of these patients are on multiple medications.
Eric H Young +4 more
doaj +1 more source
Clinical and Translational Science, 2023 Polypharmacy may cause adverse health outcomes in the elderly. This study examined the prevalence of continuous polypharmacy and hyper‐polypharmacy, factors associated with polypharmacy, and the most frequently prescribed medications among older adults ...
Ho Jin Cho +3 more
doaj +1 more source